Skip to main navigation Skip to search Skip to main content

A novel alteration in the epidermal growth factor receptor gene is frequently detected in human non-small cell lung cancer

  • Paul M. Schneider
  • , Mien Chie Hung
  • , Robert S. Ames
  • , Elizabeth A. Putnam
  • , Blanetta Akpakip
  • , Jack A. Roth
  • University of Texas Health Science Center at Houston

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

We studied 60 patients with non-small cell lung cancer (NSCLC) for alterations in the epidermal growth factor receptor (EGFR) gene. 24 60 (40%) demonstrated cleavage of a 4.2 kb EcoRI fragment in the tumor DNA which was not observed in DNA from paired normal lung. This fragment corresponds to a genomic region that encodes for part of the intracellular tyrosine kinase domain of the EGFR. We demonstrated that an alteration is present which leads to an increased cleavage efficiency of restriction endonuclease EcoRI for a specific EcoRI site in this 4.2 kb fragment.

Original languageEnglish
Pages (from-to)65-72
Number of pages8
JournalLung Cancer
Volume6
Issue number3-4
DOIs
StatePublished - Oct 1990

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Epidermal growth factor receptor
  • Lung cancer

Fingerprint

Dive into the research topics of 'A novel alteration in the epidermal growth factor receptor gene is frequently detected in human non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this